A217330 Share Price Performance
₩0
-4430.00 (-100.00%)
Price ₩0
Share Pricen/a
Market Might Still Lack Some Conviction On Cytogen, Inc. (KOSDAQ:217330) Even After 33% Share Price Boost
Dec 09
Cytogen, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A217330 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Cytogen, Inc. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -660.22
- 24.22%
- -60.70%
- 35.8%
About A217330
- Founded
- 2010
- Employees
- 50
- CEO
- WebsiteView website
Cytogen, Inc., a biotechnology company, engages in blood cancer cell-based Liquid Biopsy application business in South Korea. The company offers cell isolators that enrich CTCs from human blood and/or body fluid using high density microporous chips; IF stainers, automated immunofluorescent staining system; and cell image analyzers, which help captures immunofluorescent images of cells stained with anti-EpCAM, -CD45, and CK antibodies. The company sells its products under the Smart Biopsy brand name. Cytogen, Inc. was founded in 2010 and is headquartered in Seoul, South Korea.
